Voyager Therapeutics Inc (VYGR) Company Sales Revenue

Voyager Therapeutics specializes in developing innovative TRACER systems for the delivery of gene therapies to the CNS. The company's sales volume history helps identify entry points, while the 0.03 value reflects the metric's balance. The business relies on strict temperature control of vectors, and the steady leadership course is confirmed by the conclusion of large-scale strategic alliances in neuromedicine.
Comprehensive metric breakdowns and analytics for voyagertherapeutics.com (VYGR)

This metric is calculated as the sum of all actual cash receipts from customers for products and services sold. This metric reflects the real liquidity of the business and allows for the timely identification of cash flow gaps. For Voyager Therapeutics (VYGR), the primary source of these funds is B2B licensing agreements for the TRACER platform. The trend in the company's total sales confirms the effectiveness of scaling innovations in gene therapy. Analysis of this chart helps assess the issuer's operational resilience.